Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9626686 | 0.84 | HMGCR (0.58) | HMGCRGPR84 | |
| SCHEMBL6125719 | 0.82 | HMGCR (0.51) | HMGCRCYP3A4GPR84 | |
| SCHEMBL12003762 | 0.80 | HMGCR (0.45) | HMGCR | |
| SCHEMBL2393546 | 0.79 | HMGCR (0.38) | HMGCRUSP2CYP3A4SMN1; SMN2GPR84 | |
| SCHEMBL736276 | 0.78 | HMGCR (0.53) | HMGCRCYP3A4SMN1; SMN2 | |
| SCHEMBL6137642 | 0.76 | HMGCR (0.51) | HMGCRGPR84 | |
| Acetic Acid SCHEMBL10540684 | 0.76 | HMGCR (0.63) | HMGCRGPR84 | |
| SCHEMBL6137648 | 0.76 | HMGCR (0.51) | HMGCRGPR84 | |
| SCHEMBL26421490 | 0.76 | HMGCR (0.41) | HMGCR | |
| SCHEMBL10352754 | 0.76 | HMGCR (0.45) | HMGCRCYP3A4GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110224340-A1 | Method for Producing Mono-Vinylfunctionalized Dialkylphosphinic Acids, Salts and Esters Thereof, and the Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224340-A1 | Method for Producing Mono-Vinylfunctionalized Dialkylphosphinic Acids, Salts and Esters Thereof, and the Use Thereof | ACSL1, ACSL3, HACL2 | HMGCR 500/4885USP2 3571/4885CYP3A4 2557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.